Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Hepatology (Baltimore, Md.)|September 8, 2011
Field-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in ItalyMassimo Iavarone, Giuseppe Cabibbo, Fabio Piscaglia, et al.
European Journal of Gastroenterology & Hepatology|October 10, 2012
Adverse events affect sorafenib efficacy in patients with recurrent hepatocellular carcinoma after liver transplantation: experience at a single center and review of the literatureClaudio Zavaglia, Aldo Airoldi, Andrea Mancuso, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 3, 2015
Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: a systematic review and meta-analysisAndrea Mancuso, Alessandra Mazzola, Giuseppe Cabibbo, et al.
Cancer Letters|April 24, 2004
Codon 72 polymorphism of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patientsMichela Leveri, Chiara Gritti, Laura Rossi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 18, 2014
Prognostic factors of hepatic decompensation and hepatocellular carcinoma in patients with transfusion-acquired HCV infectionClaudio Zavaglia, Enrico Silini, Alessandra Mangia, et al.
Journal of Hepatology|September 16, 2003
Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patientsLaura Rossi, Michela Leveri, Chiara Gritti, et al.
European Journal of Gastroenterology & Hepatology|February 28, 2008
Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?Claudio Zavaglia, Rocco Corso, Antonio Rampoldi, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver diseaseLaura Sonzogni, Laura Silvestri, Annalisa De Silvestri, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaCalogero Cammà, Giuseppe Cabibbo, Salvatore Petta, et al.
International Journal of Cancer|February 6, 2003
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancerLaura Silvestri, Laura Sonzogni, Annalisa De Silvestri, et al.
Pageof 2